---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-000516"
form_type: "8-K"
ticker: "CBIO"
cik: "0001253689"
company_name: "CRESCENT BIOPHARMA, INC."
filed_at: "2022-01-27T23:59:59+00:00"
generated_at: "2026-06-27T14:47:41.571733+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# GlycoMimetics awards retention bonuses to CFO, CBO, CSO; induces plan shares to 3M

## Summary
- CFO Brian Hahn and CBO Armand Girard eligible for retention bonus up to 60% of base salary; CSO John Magnani up to 20%.
- 40% of bonus payable Aug 1, 2022; remaining 60% payable Aug 1, 2023, contingent on continued employment through each date.
- Inducement Plan share reserve increased from 2M to 3M shares to support equity awards.

## SEC filing metadata
- accession: 0001558370-22-000516
- form_type: 8-K
- ticker: CBIO
- cik: 0001253689
- company_name: CRESCENT BIOPHARMA, INC.
- filed_at: 2022-01-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1253689/000155837022000516/0001558370-22-000516-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1253689/000155837022000516/glyc-20220121x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-000516
- JSON: https://secwatch.observer/filing/0001558370-22-000516.json
- Plain text: https://secwatch.observer/filing/0001558370-22-000516.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.